|
Connolly Bove Lodge & Hutz LLP
|
Richard E. Caruso, Ph.D.
Integra LifeSciences Holdings, Inc., Founder & Chairman
Dr. Caruso is the founder and chairman of Integra LifeSciences, as well as at least half a dozen other successful companies. In 2006, Dr. Caruso was named the Ernst and Young National Entrepreneur of the Year for the United States. Dr. Caruso is currently founder of The Provco Group, www.provcogroup.com, an advisor to Quaker BioVentures, a member of the Board of Directors of Nitric Biotherapeutics, Inc. and Diasome Pharmaceuticals, LLC, a founder of Smart Personalized Medicine, a managing partner of CeeLite Technologies and an advisor to NewSpring Capital and ePlanet Ventures III. |
Gerianne Tringali DiPiano
FemmePharma Global Healthcare, Inc. Founder, President & CEO
 Ms. Tringali DiPiano is the founder of FemmePharma Global Healthcare, Inc., www.femmepharma inc.com, where she currently serves as President, CEO and Chairman of its Board of Directors. She has over over two decades of experience in the pharmaceutical industry and has worked extensively in women's health in sales, marketing, medical affairs, and new product and business development. Among other positions, she currently serves on the Board of Trustees for Drexel University, the Corporate Advisory Board of the Society for Gynecologic Investigation, and the Editorial Advisory Board of Biotechnology Healthcare. Ms. Tringali DiPiano was named as one the 100 most inspiring individuals in the United States' Pharmaceutical Industry and was recognized by Governor Rendell as one of Pennsylvania's 51 Best Women In Business in 2007 in addition to several other prestigious honors. |
David R. King
Quaker BioVentures,Venture Partner
Mr. King is a venture partner with Quaker BioVentures, a venture capital firm with $700 million under management, dedicated to investing in life science companies in the Mid-Atlantic region and contiguous states, www.quakerbio.com.
Mr. King is also executive chairman of Diasome Pharmaceuticals, Inc., which is developing unique, orally available and targeted insulin therapies for the improved treatment of diabetes.
|
Calvin H. Knowlton, Ph.D.
RevolutionCare,Chairman & CEO
A legend for the success of his numerous start-up companies including excelleRX, Dr. Calvin Knowlton currently serves as Chairman and CEO of RevolutionCare, www.rev-care.com. Dr. Knowlton is the current President of the American Pharmacists Association and previously served as the National President for the American College of Apothecaries and the American Pharmaceutical Association. He is well known for his unique entrepreneurial, leadership, and management skills and has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 30 years. |
|
Warren V. "Pete" Musser
The Musser Group, President & CEO
Mr. Musser has been a leading figure in the business world as both an entrepreneur and a chief executive for more than 50 years. He is perhaps best known for his role at Safeguard Scientifics, Inc. As the Chairman of the Board and CEO from 1953 until 2001, he facilitated the formation and success of many of today's top Fortune companies, including QVC, Comcast, Novell, Inc., and many other successful companies. Today, Mr. Musser continues to serve as Chairman Emeritus of Safeguard, and as the President and CEO of The Musser Group, a financial consulting company, www.themussergroup.com. He is also Director of Internet Capital Group, Inc., NutriSystem, Inc., Telkonet, Inc. and Health Benefits Direct Corp. |
Paul M. Simon, Ph. D.
Augmenta Biologicals, LLC, Founder, President &CSO
Dr. Simon, with 27 years of experience directing discovery R&D in big and small biopharmaceutical companies, is the founder, President and Chief Scientific Officer of Augmenta Biologicals, LLC, www.augmentabio. com. Dr. Simon's work has encompassed several types of immunotherapy (cell therapy, transplantation, therapeutic monoclonal antibodies) as well as research in inflammatory, infectious and inflammatory diseases.
|
Jack E. Stover
TNT Pharma, Executive Chairman
 Mr. Stover is currently Executive Chairman of Targeted Nano Therapeutics, a privately-held, virtual biotechnology company, www.tntpharma.com. Previously Mr. Stover was CEO, Vice Chairman and Director of Antares Pharma Inc., a publically held specialty pharmaceutical company. Mr. Stover has held various senior positions with other life science companies, was formerly a partner with Pricewaterhouse Coopers LLC and was Chairman of the Board of the Ben Franklin Advanced Technology Center at Lehigh University. Mr. Stover has over 20 years of experience as a board member of public life sciences companies including PDI, Inc, a contract sales and marketing company, and Arbios Technologies, Inc., a bio-artificial liver company. |
|
|
|
Please join Connolly Bove Lodge & Hutz LLP on Wednesday, June 2, 2010 for our first annual Life Sciences Forum.
The conference will be held at the Radnor Hotel in St. Davids, Pennsylvania from 3:30 PM to 7:30 PM. |
|
Agenda
3:30 PM to 4:30 PM Registration
4:30 PM to 4:50 PM Introduction
4:50 PM to 5:40 PM Panel 1: Life Science Investments
- Characteristics of Life Science Companies Being Funded in the Delaware Valley
- Funding Resources in the Delaware Valley
- Investing in Life Science Companies vs. Other Technology Companies
- The Climate of the Delaware Valley Investment Community vs. Other Areas
5:40 PM to 6:30 PM Panel 2: Life Science Innovations
-
How Healthcare Reform Legislation "Obama Care" May Affect Life Science Companies
-
The Current State and Direction of Life Science Companies in the Delaware Valley
-
The Strengths and Pitfalls of Starting a Life Science Company in the Delaware Valley
-
How Proper IP Protection Positions Companies for Investment and Growth
6:30 PM to 7:30 PM Networking, Cocktails & Hors d'oeuvres |
|
|
The Radnor Hotel
591 East Lancaster Avenue
St. Davids, PA 19087
For directions, click here.
RSVP: Please contact Diane Ketler at dketler@cblh.com or by phone at
302-888-6205. |
|
|
